Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles

Open Access

Research Article

JCR. 2020; 7(10): 2798-2803


Dr. Paramjit Kaur Khinda, Dr. Dinesh Rao, Dr. SPS Sodhi, Dr. Sanjeev Salaria.

In the pathogenesis of severe periodontitis, there is increasing evidence regarding the involvement of herpes
viral, bacterial and host immune factors but there is no clarity on the relative importance of each of these factors.
Herpes viruses are re-activated by immunosuppressive factors and, maybe for this reason, they are also major
risk factors for periodontitis. When the periodontitis is in a progressive phase, it seems that the inflamed
periodontium is a major site for accumulation and re-activation of Epstein-Barr virus and cytomegalovirus.
Matrix metalloproteinases and osteoclasts are activated by cytokines. Cytokines in turn are released by herpes
viruses. Herpes viruses may thus act as pathogens in the progression of periodontitis. Antibacterial immune
mechanisms are weakened because of an active herpesvirus infection resulting in a rise in the number of bacteria
which are considered to be periodontopathogens. A suppressed herpesvesvirus infection may be re-activated by
some of the periodontopathogenic bacteria. This synergy between the bacteria and herpesviruses may play a
significant part in the commencement and advancement of periodontitis. Herpesvirus-induced periodontitis
suggests that the immunity against herpesviruses forms a crucial feature in attaining a stable periodontium.
There is a need for further investigation on the part played by herpesviruses in periodontitis which will result in
enhanced diagnosis, better therapy and disease prevention. Vaccines specific to human cytomegalovirus
(HCMV) and Epstein Barr virus (EBV) that shape treatment strategies against herpesvirus, may be effectively
utilized in the inhibition and therapy for diseases of periodontal origin, specifically the periodontitis.

Key words: herpes viruses, periodontitis, pathogenesis, bacteria

Similar Articles

Enhancing Cr(VI) bio-reduction by conductive materials and enrichment of functional microbes under anaerobic conditions.
Chen F, Lei P, He P, Gu C, Chen Y, Zhang K, Zhu J, Gan M
Chemosphere. 2022; 287(Pt 2): 132150

Biochemical composite material using corncob powder as a carrier material for ureolytic bacteria in soil cadmium immobilization.
Li W, Yang Y, Achal V
The Science of the total environment. 2022; 802(): 149802

induces innate cytokine responses that potentially provide a protective benefit against COVID-19: A single-arm, double-blind, prospective trial combined with an cytokine response assay.
Kageyama Y, Nishizaki Y, Aida K, Yayama K, Ebisui T, Akiyama T, Nakamura T
Experimental and therapeutic medicine. 2022; 23(1): 20

Rates of Coinfection Between SARS-CoV-2 and Other Respiratory Viruses in Korea.
Kim YG, Park H, Kim SY, Hong KH, Kim MJ, Lee JS, Park SS, Seong MW
Annals of laboratory medicine. 2022; 42(1): 110-112

Challenges in Veterinary Vaccine Development.
Thomas S, Abraham A, Rodríguez-Mallon A, Unajak S, Bannantine JP
Methods in molecular biology (Clifton, N.J.). 2022; 2411(): 3-34

Full-text options

Latest Statistics about COVID-19
• pubstat.org

Add your Article(s) to Indexes
• citeindex.org

Covid-19 Trends and Statistics
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.

ScopeMed Web Sites